Catalyst Biosciences' Corporate Minority Round

Catalyst Biosciences raised a round of funding on January 06, 2012. Investors include Pfizer.

Catalyst Biosciences is developing next generation biopharmaceuticals by harnessing the catalytic power of engineered proteases that target proteins underlying diseases. Catalyst's discovery platform …

Articles about Catalyst Biosciences' Corporate Minority Round: